Jun 10, 2020
COTA Supports FDA Assessment of Real-World Data through Membership in COVID-19 Evidence Accelerator
Jun 04, 2020
Therapeutic Solutions International Announces Positive Preclinical and Clinical Evaluation of Nutritional Supplement QuadraMune(TM), Designed to Protect Against COVID-19
May 27, 2020
Hackensack Meridian Health Observational Study Demonstrates Lack of Efficacy of Hydroxychloroquine Among Hospitalized COVID-19 Patients But Finds First Treatment (tocilizumab) to Improve Survival
Apr 24, 2020
Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
Apr 16, 2020
Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19
Apr 03, 2020
Case Study: Treating COVID-19 in a Patient with Multiple Myeloma
Mar 26, 2020
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Feb 05, 2020
CytoSorb Used Successfully to Help Treat Grade 4 Cytokine Release Syndrome Following CAR T-cell Immunotherapy in First Published Case Report
Sep 25, 2019
Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Insights, Epidemiology and Market Forecasts, 2017-2028
Jun 17, 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
Dec 04, 2018
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018
Oct 22, 2018
Mallinckrodt Presents Data on H.P. Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting
May 10, 2018
Warning to Eli Lilly's Olumiant (baricitinib): Entrenched First-to-Market Rheumatoid Arthritis Products are Tough to Unseat
Nov 21, 2017
Recent Chart Audit Reveals Switching Rheumatoid Arthritis Patients to Roche/Genentech's RoActemra (Actemra) is Significantly More Common in the EU5 than it is in the US
Nov 10, 2017
Rheumatoid Arthritis (RA) Drugs Market 2017-2027
Oct 23, 2017
US Rheumatologists Report that Use of Biologic/JAK Monotherapy in Rheumatoid Arthritis is Greatest for Pfizer's Xeljanz, Roche/Genentech's Actemra, and Sanofi/Regeneron's Recently Launched Kevzara
Aug 09, 2017
Likely Delay for GSK/Janssen's Sirukumab Sets up Head to Head Battle Between Roche/Genentech's Actemra and Sanofi/Regeneron's Kevzara in the US Rheumatoid Arthritis Market
Jul 21, 2017
Rheumatoid Arthritis Drug, Actemra, Tied to Significant Side Effects